INRIG JULA

PrivateCIK: 1902368
Location

SAN DIEGO, CA

INRIG JULA (Chief Medical Officer) sold 16.6% of their position (22.48K shares) of TRAVERE THERAPEUTICS, INC. on the open market

Open‑market sale worth $1.02M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales
InsiderINRIG JULACIK 1902368
Officer· Chief Medical Officer
Since Jan 2022
-13.98K
Net shares
Net seller
$1.02M
Total sold
3
Open market trades
0B · 3S
8
Total transactions
32.75K acquired · 46.73K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+20K

Price / share

$22.40

Trade value

$448K

% of position

17.9%
5/4/2026
111.47K131.47K

Common Stock

Direct
S · Sale

Shares

20K

Price / share

$45.00

Trade value

$900K

% of position

15.2%
5/4/2026
131.47K111.47K

Common Stock

Direct
M · Option Exercise

Shares

+4.25K

Price / share

Trade value

% of position

3.8%
5/4/2026
111.47K115.72K

Common Stock

Direct
S · Sale

Shares

2.17K

Price / share

$46.65

Trade value

$101.42K

% of position

1.9%
5/5/2026
115.72K113.55K

Common Stock

Direct
S · Sale

Shares

311.00

Price / share

$43.95

Trade value

$13.67K

% of position

0.3%
5/6/2026
113.55K113.24K
Total

Net shares

+1.76K

Net value

-$567.09K

Derivative Transactions3

Employee stock option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

20K shares

Shares

20K

Strike price

22.40

Held after

34.50K

Exercisable

5/4/2026

Performance-based restricted stock units

Direct
A · Award
Converts to

Common Stock

8.50K shares

Shares

+8.50K

Strike price

Held after

8.50K

Exercisable

5/4/2026

Performance-based restricted stock units

Direct
M · Option Exercise
Converts to

Common Stock

4.25K shares

Shares

4.25K

Strike price

Held after

4.25K

Exercisable

5/4/2026
INRIG JULA — Insider Transaction (Form 4) Filed May 7, 2026 | Finecho